Concepedia

Publication | Closed Access

Therapeutic Approach by a Novel Designed Anti-Inflammatory Drug, M2000, in Experimental Immune Complex Glomerulonephritis

42

Citations

14

References

2007

Year

Abstract

These findings suggest that treatment with M2000 can reduce proteinuria, diminish antibody production, and suppress the progression of disease in a rat model of immune complex glomerulonephritis.

References

YearCitations

Page 1